LEI 969500V3ZSEMKHQ9TA17

INSERM TRANSFERT

Awards tracked

54

Value

€18.3M

Countries

FR

Download sample CSV

Contract awards & public grants

Microbiota–Immune–Cognition Relationships from Neonatal Environments to Social Trajectories → INSERM TRANSFERT SA

European Commission · FR · Grant · 2026-05-13

€207,813

Assessing and improving access to health and social care SErvices for children RENdered vulnerable by Abuse → INSERM TRANSFERT SA

European Commission · FR · Grant · 2024-12-06

€397,640

A European Proactive Adaptive Clinical Trials Network within EU-Response → INSERM TRANSFERT SA

European Commission · FR · Grant · 2024-12-06

€516,413

Offering combined HPV vaccination and HPV test-based cervical screening to vulnerable populations. A hybrid efficacy and implementation study. → INSERM TRANSFERT SA

European Commission · FR · Grant · 2024-12-05

€354,549

Building a European strategic Research and Innovation Area in Direct Synergy with EU and International Initiatives for Pandemic Preparedness PLUS → INSERM TRANSFERT SA

European Commission · FR · Grant · 2024-12-05

€108,025

IMPROVing lifElong health and development for children and adults born very PRETERM – observational studies to enhance randomised trials for comparati → INSERM TRANSFERT SA

European Commission · FR · Grant · 2024-12-03

€393,745

Dissecting Brain Pollutant Exposure and its Contribution to Neurodegeneration and Alzheimer’s disease: From Signatures to Prevention Strategies to Pro → INSERM TRANSFERT SA

European Commission · FR · Grant · 2024-11-07

€393,000

Sustainable COVID-19 Vaccination for Long-term Vaccine Immunity and Effectiveness → INSERM TRANSFERT SA

European Commission · FR · Grant · 2023-12-08

€389,645

Innovative designs, extrapolation, simulation methods and evidence-tools for rare diseases addressing regulatory needs → INSERM TRANSFERT SA

European Commission · FR · Grant · 2023-11-16

€411,375

Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy (MITI2) → INSERM TRANSFERT SA

European Commission · FR · Grant · 2023-04-28

€467,934

Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe) → INSERM TRANSFERT SA

European Commission · FR · Grant · 2023-04-27

€352,125

A clinical research network to improve the management of Monkeypox virus disease → INSERM TRANSFERT SA

European Commission · FR · Grant · 2023-04-14

€335,123

Fighting childhood obesity to stay healthy all over the life → INSERM TRANSFERT SA

European Commission · FR · Grant · 2023-04-07

€512,750

Early Interception of Inflammatory-mediated Type 2 Diabetes → INSERM TRANSFERT SA

European Commission · FR · Grant · 2022-11-23

€400,375

Improving treatment efficacy in hypertension by biomarker-guided personalised decision support → INSERM TRANSFERT SA

European Commission · FR · Grant · 2022-11-22

€924,250

CArdiovascularREsolution of INflammation to promote HEALTH → INSERM TRANSFERT SA

European Commission · FR · Grant · 2022-11-15

€151,943

Building a European strategic Research and Innovation Area in Direct Synergy with EU and International Initiatives for Pandemic Preparedness → INSERM TRANSFERT SA

European Commission · FR · Grant · 2022-06-29

€198,375

SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients → INSERM TRANSFERT SA

European Commission · FR · Grant · 2022-06-02

€356,500

Cardiac regeneration by mRNA-triggered proliferation of cardiomyocytes → INSERM TRANSFERT SA

European Commission · FR · Grant · 2022-05-18

€398,975

A Coordination and Support Action to prepare UNCAN.eu platform → INSERM TRANSFERT SA

European Commission · FR · Grant · 2022-05-17

€217,500

Integrated Services for Infectious Disease Outbreak Research → INSERM TRANSFERT SA

European Commission · FR · Grant · 2022-02-09

€191,918

Working collaboratively with vulnerable women to identify the best implementation gains by screening cervical cancer more effectively in European coun → INSERM TRANSFERT SA

European Commission · FR · Grant · 2021-02-02

€254,500

Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trial → INSERM TRANSFERT SA

European Commission · FR · Grant · 2021-01-18

€365,875

European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases → INSERM TRANSFERT SA

European Commission · FR · Grant · 2020-09-03

€389,138

Modern approaches for developing antivirals against SARS-CoV 2 → INSERM TRANSFERT SA

European Commission · FR · Grant · 2020-08-11

€269,875

Corona Accelerated R&D in Europe → INSERM TRANSFERT SA

European Commission · FR · Grant · 2020-08-07

€450,000

Impact of exposome on the course of lung diseases → INSERM TRANSFERT SA

European Commission · FR · Grant · 2019-12-06

€442,165

FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA → INSERM TRANSFERT SA

European Commission · FR · Grant · 2019-12-06

€247,875

Brain injury in the premature born infant: stem cell regeneration research network → INSERM TRANSFERT SA

European Commission · FR · Grant · 2019-12-06

€314,715

Associative mechanisms linking a defective minipuberty to the appearance of mental and nonmental disorders: infantile NO replenishment as a new therap → INSERM TRANSFERT SA

European Commission · FR · Grant · 2019-12-05

€390,993

Immune profiling to guide host-directed interventions to cure HBV infections → INSERM TRANSFERT SA

European Commission · FR · Grant · 2019-12-05

€300,000

Human Gonad Developmental Cell Atlas → INSERM TRANSFERT SA

European Commission · FR · Grant · 2019-11-24

€309,200

Gene Therapy to restore lymphatic flow lymphedema → INSERM TRANSFERT SA

European Commission · FR · Grant · 2019-11-24

€214,500

Antibiotic Distribution and Recovery in Tissue → INSERM TRANSFERT SA

European Commission · FR · Grant · 2019-06-25

€335,625

CARdiomyopathy in type 2 DIAbetes mellitus → INSERM TRANSFERT SA

European Commission · FR · Grant · 2019-04-11

€310,250

European Joint Programme on Rare Diseases → INSERM TRANSFERT SA

European Commission · FR · Grant · 2018-12-13

€366,765

Integrating Environment and Health Research: a Vision for the EU → INSERM TRANSFERT SA

European Commission · FR · Grant · 2018-12-10

€154,219

Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics → INSERM TRANSFERT SA

European Commission · FR · Grant · 2018-12-10

€245,250

An integrative strategy of testing systems for identification of EDs related to metabolic disorders → INSERM TRANSFERT SA

European Commission · FR · Grant · 2018-11-21

€379,750

Advancing European Research Infrastcuture on Highly Pathogenic Agents → INSERM TRANSFERT SA

European Commission · FR · Grant · 2018-11-20

€283,250

European Brain Research Area → INSERM TRANSFERT SA

European Commission · FR · Grant · 2018-10-24

—

The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients → INSERM TRANSFERT SA

European Commission · FR · Grant · 2017-11-27

€416,921

Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative → INSERM TRANSFERT SA

European Commission · FR · Grant · 2017-11-21

€349,000

A global alliance for Zika virus control and prevention → INSERM TRANSFERT SA

European Commission · FR · Grant · 2016-12-13

€362,625

Crimean-Congo Haemorrhagic Fever Vaccine → INSERM TRANSFERT SA

European Commission · FR · Grant · 2016-12-09

€401,875

European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates → INSERM TRANSFERT SA

European Commission · FR · Grant · 2015-12-17

€580,710

Investigating the impact of meditation training on mental health and wellbeing in the ageing population → INSERM TRANSFERT SA

European Commission · FR · Grant · 2015-12-09

€151,675

European Research Infrastructure on Highly Pathogenic Agents 2 → INSERM TRANSFERT SA

European Commission · FR · Grant · 2015-10-08

€177,437

Coordination Action in support of the sustainability and globalisation of the Joint Programming Initiative on Neurodegenerative Diseases → INSERM TRANSFERT SA

European Commission · FR · Grant · 2015-08-19

€279,625

Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized cli → INSERM TRANSFERT SA

European Commission · FR · Grant · 2015-04-14

€389,491

Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension → INSERM TRANSFERT SA

European Commission · FR · Grant · 2015-04-13

€408,374

Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis → INSERM TRANSFERT SA

European Commission · FR · Grant · 2015-04-07

€421,000

Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861 → INSERM TRANSFERT SA

European Commission · FR · Grant · 2015-03-06

€427,090

Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics – Sofia ref.: 115843 → INSERM TRANSFERT SA

European Commission · FR · Grant · 2015-01-21

€231,000

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.